|
KLHDC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64934732538313E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.21893639415794E-12 |
| Normal-vs-Stage2 |
1.198220E-02 |
| Normal-vs-Stage3 |
9.316400E-03 |
| Normal-vs-Stage4 |
8.977000E-01 |
| Stage1-vs-Stage2 |
2.079600E-01 |
| Stage1-vs-Stage3 |
4.041000E-01 |
| Stage1-vs-Stage4 |
1.132130E-02 |
| Stage2-vs-Stage3 |
6.831200E-01 |
| Stage2-vs-Stage4 |
9.610100E-02 |
| Stage3-vs-Stage4 |
1.001440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62714286489063E-12 |
| Normal-vs-AfricanAmerican |
3.559500E-04 |
| Normal-vs-Asian |
3.241800E-01 |
| Caucasian-vs-AfricanAmerican |
3.130600E-01 |
| Caucasian-vs-Asian |
2.400600E-01 |
| AfricanAmerican-vs-Asian |
5.846200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.69553260320754E-12 |
| Normal-vs-Female |
8.96380000003916E-07 |
| Male-vs-Female |
6.868000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.388500E-04 |
| Normal-vs-Extreme_Weight |
1.47819534390692E-11 |
| Normal-vs-Obese |
8.00370000053618E-07 |
| Normal-vs-Extreme_Obese |
7.961900E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.463380E-01 |
| Normal_Weight-vs-Obese |
4.108800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.329200E-01 |
| Extreme_Weight-vs-Obese |
6.075800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.258000E-01 |
| Obese-vs-Extreme_Obese |
4.330600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.611200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.68370000164231E-08 |
| Normal-vs-Age(61-80Yrs) |
1.74893433069201E-12 |
| Normal-vs-Age(81-100Yrs) |
1.621800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.087200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.025000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.126800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.098600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.145600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.001400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.55191440096314E-15 |
| Normal-VS-Type2 PRCC |
3.431200E-04 |
| Normal-VS-KIRP CIMP |
7.801000E-01 |
| Normal-VS-Unclassified PRCC |
5.29570000074031E-08 |
| Type1 PRCC-VS-Type2 PRCC |
4.219500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.803980E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.474800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.320600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.895600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.918600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.390420E-04 |
| Normal-vs-N1 |
8.060500E-02 |
| Normal-vs-N2 |
6.438000E-01 |
| N0-vs-N1 |
3.694000E-01 |
| N0-vs-N2 |
5.189400E-01 |
| N1-vs-N2 |
8.412200E-01 |
|
|
